Posted on: 23 September, 2024
Two of the Kolling Institute’s emerging leaders are gaining attention after receiving the ATA Scientific Encouragement Award.
The award, which was launched more than a decade ago, aims to provide young scientists with financial assistance to further their education and attend scientific meetings and conferences.
Scientific officer Kevin Winardi from the Kolling’s Lab of Ageing and Pharmacology will.....
Read more
Category: Awards, Neuroscience and Pain Research, Research Excellence
Posted on: 09 September, 2024
Our researchers at the Kolling Institute have joined with international collaborators to develop a revolutionary implant for hip replacements.
The ceramic implant, designed for hip resurfacing procedures, doesn’t require the long stem used in common hip replacements.
This means surgeons are not removing the bone which they would generally remove for a hip replacement.
Professor Bill Walter, a leadi.....
Read more
Category: Musculoskeletal Research, World-leading technology
Posted on: 02 September, 2024
Related content
Back Pain Research
Osteoarthritis Research
Musculoskeletal
Donate
Read more
Category: Musculoskeletal Research, Neuroscience and Pain Research
Posted on: 26 August, 2024
Generous community support is strengthening our research into oesophageal cancer, lifting hopes of improved treatments for the aggressive and deadly cancer.
The Fight for a Cure charity has donated $100,000 towards Dr Colby Stevenson’s research, on top of a $100,000 donation from the Howlett family, in memory of their son Scott who died from the cancer.
The Howlett family has welcomed the research .....
Read more
Category: Funding support, Research Excellence
Posted on: 22 August, 2024
Researchers at the Kolling Institute have welcomed the launch of Australia's premier cancer clinical trials centre on the Royal North Shore Hospital campus.
NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg.
The centre is a ground-breaking partnership between Northern Sydney Local .....
Read more
Category: Funding support, New Treatment, Research Excellence
Posted on: 15 August, 2024
Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science developing the first humanised model of the disease ahead of gene therapy.
The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez-Escamez who relocated from Spain to the institute to pursue his ground-breaking work.
His talented team of seven .....
Read more
Category: Neuroscience and Pain Research, Research Excellence, World-leading technology
Posted on: 12 August, 2024
We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory.
Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s estimated up to 125 million people will have the con.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 07 August, 2024
Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute.
Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders.
Our teams have continued to increase their research impact, while forging.....
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 05 August, 2024
Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team.
The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia.
This form of blood cancer is particularly aggressive, with less .....
Read more
Category: Funding support, Research Excellence
Posted on: 31 July, 2024
A team of researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research has launched a study to develop the first internationally accepted guidelines for assessing cognitive function after a spinal cord injury.
The latest data indicates that over 15 million people globally live with a spinal cord injury, and in Australia, there are over 20,000 people living with the injury......
Read more
Category: Neuroscience and Pain Research, Research Excellence